Warner Bros. Discovery, Inc.
TRICYCLIC COMPUND AS CRTH2 INHIBITOR
Last updated:
Abstract:
Provided are a tricyclic compound as shown in formula (I) as a CRTH2 inhibitor, or a pharmaceutically acceptable salt, a tautomer, a stereoisomer or a solvate thereof, and the use thereof in treating diseases related to CRTH2 receptors. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
21 Jul 2017
Issue date:
30 Dec 2021